Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 298.00
Ask: 301.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.007%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Jun 2012 11:31

RNS Number : 8748F
Oxford Biomedica PLC
21 June 2012
 



Financial Services Authority

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Oxford Biomedica Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to thenotification obligation:

Legal & General Group Plc (L&G)

4. Full name of shareholder(s)  (if different from 3.):

N/A

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

 

19 June 2012

6. Date on which issuer notified:

20 June 2012

7. Threshold(s) that is/are crossed orreached:

 

L&G (Below 3%)

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

Ordinary 1p

 21,605,215

 

(As on 16/06/2010)

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

Below 3%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)

Legal & General Investment Management Limited (Indirect) (LGIM)

Legal & General Group Plc (Direct) (L&G) (Below 3% = LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of  944,875,557

 

14. Contact name:

Paul Toon (LGIM)

15. Contact telephone number:

020 3124 3854

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAURRUKANUAR
Date   Source Headline
1st Jul 20229:55 amRNSTotal Voting Rights
1st Jul 20227:00 amRNSSigns new agreement with AstraZeneca
14th Jun 20227:00 amRNSNotes FDA lift clinical hold on pheNIX trial
1st Jun 20227:00 amRNSTotal Voting Rights
27th May 20226:03 pmRNSResult of AGM
3rd May 20225:18 pmRNSGrant of options
3rd May 20224:46 pmRNSDirector/PDMR Shareholding
3rd May 202210:35 amRNSTotal Voting Rights
29th Apr 20225:42 pmRNSDirectors Dealings / Market Share Purchases
28th Apr 20222:24 pmRNSDirector/PDMR Shareholding
27th Apr 20222:58 pmRNS2021 Annual report and accounts & AGM notification
27th Apr 202212:10 pmRNSPDMR Dealings / Market Share Purchase
21st Apr 20224:41 pmRNSDirector Share Purchase
21st Apr 20221:24 pmRNSDirectors Dealings / Market Share Purchase
21st Apr 202210:16 amRNSDirector/PDMR Shareholding
20th Apr 20223:45 pmRNSDirector/PDMR Shareholding
20th Apr 20227:00 amRNSPreliminary Results
13th Apr 20227:00 amRNSBoard Appointment
4th Apr 202211:34 amRNSNotice of Preliminary Results
1st Apr 20226:30 pmRNSHolding(s) in Company
1st Apr 202210:33 amRNSBlock listing Application
1st Apr 20229:34 amRNSTotal Voting Rights
31st Mar 20226:07 pmRNSHolding(s) in Company
30th Mar 20221:00 pmRNSHolding(s) in Company
25th Mar 20225:15 pmRNSHolding(s) in Company
21st Mar 202210:44 amRNSLong Term Incentive Plan Option Grant
15th Mar 202211:25 amRNSHolding(s) in Company
15th Mar 20229:39 amRNSHolding(s) in Company
11th Mar 20224:51 pmRNSHolding(s) in Company
11th Mar 20229:01 amRNSAdmission of Conditional Placing Shares
10th Mar 20225:32 pmRNSCompletion of Transaction
9th Mar 202211:42 amRNSDirector Declaration
8th Mar 20223:54 pmRNSResult of General Meeting
1st Mar 20229:52 amRNSTotal Voting Rights
16th Feb 202211:41 amRNSPublication of Circular & Notice of GM
4th Feb 20228:22 amRNSAdmission of Firm Placing Shares
1st Feb 20229:06 amRNSTotal Voting Rights
1st Feb 20227:00 amRNSUpdate to agreement with Sio Gene Therapies
31st Jan 202211:21 amRNSMarket Share Purchase
28th Jan 20225:59 pmRNSResult of Placing and PrimaryBid offer
28th Jan 20222:04 pmRNSHoldings in Company
28th Jan 20227:38 amRNSRetail offer by PrimaryBid
28th Jan 20227:24 amRNSUS Agreement and Proposed Placing of Shares
17th Jan 20227:00 amRNSJohn Dawson to retire from Oxford Biomedica
5th Jan 20227:00 amRNSOxford Biomedica Agreement with Cabaletta Bio
4th Jan 202211:07 amRNSBlock listing Return
4th Jan 202210:32 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSJohn Dawson awarded CBE in New Year Honours List
14th Dec 20217:00 amRNSBoard Appointment
13th Dec 20217:00 amRNSOxford Biomedica Updates Lentiviral Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.